TG Therapeutics Inc (TGTX)
Total asset turnover
Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 262,359 | 340,582 | 280,254 | 222,343 | 180,883 | 18,875 | 6,331 | 2,784 | 5,025 | 6,961 | 7,912 | 6,689 | 4,406 | 2,414 | 907 | 152 | 152 | 152 | 152 | 152 |
Total assets | US$ in thousands | 586,014 | 401,207 | 373,323 | 329,587 | 331,067 | 220,854 | 197,358 | 193,572 | 217,891 | 251,666 | 303,028 | 379,629 | 409,687 | 481,400 | 548,699 | 625,642 | 273,856 | 294,621 | 101,849 | 163,014 |
Total asset turnover | 0.45 | 0.85 | 0.75 | 0.67 | 0.55 | 0.09 | 0.03 | 0.01 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
September 30, 2024 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $262,359K ÷ $586,014K
= 0.45
Total asset turnover measures a company's efficiency in generating sales revenue from its assets. It is calculated by dividing total revenue by average total assets. For TG Therapeutics Inc, the total asset turnover has fluctuated over the periods analysed.
In the most recent period, September 2024, the total asset turnover is 0.45, indicating that the company is generating 45 cents of revenue for every dollar of assets. This is a decrease from the previous quarter, June 2024, where the turnover was 0.85, suggesting a decline in the company's efficiency in utilizing its assets to generate revenue.
The highest total asset turnover was observed in June 2023 at 0.09, which was significantly higher than the turnovers in the previous periods. This could indicate a period of improved asset utilization efficiency. However, the turnover in the subsequent periods remained low, indicating a possible anomaly or specific event impacting the company's operations during that quarter.
Overall, the trend in TG Therapeutics Inc's total asset turnover shows variability, suggesting fluctuations in the company's ability to efficiently generate sales revenue from its assets. This metric is important for investors and analysts to assess the company's operational efficiency and resource utilization. Further analysis of the company's financial and operational performance is recommended to understand the factors contributing to the fluctuations in total asset turnover over time.
Peer comparison
Sep 30, 2024